2009

41-60 of 263 < first | | | last >
  • 2011 Pharma Job Market: Is the Pendulum Swinging Workers' Way?

    After a forgettable few years of pharma industry workers being maxed out, stressed out, or laid off, 2011 finally promises a turnaround. Biotech is already hiring manufacturing workers, says Megan Driscoll, president of Pharmalogics Recruiting, while traditional pharma should follow suit later in the year. The change is more than welcome, says Driscoll, as burnout is a real issue for workers, who have had no choice but to take on more responsibilities or risk being let go. Manufacturers, too, will have to reward workers who have seen them through tough times.

    01/27/2011
  • Webcast: From Cleaning Validation to Cleaning Verification: Make the Move to a New Model

    Join us on February 17, 2011, at 11 a.m. ET to learn more about why cleaning validation issues have ranked in the top five for FDA warning letters. With the advent of new online technologies and changes in the regulatory approach to validation, traditional cleaning validation can move more towards a mode of cleaning verification. This presentation will describe the whys and wherefores of cleaning validation with recommendations of procedures and interpretation. Data on a new approach for screening and specific analysis using charged aerosol detection with FIA and UHPLC will be presented. Live Q+A will follow-bring your questions for the experts.

    01/11/2011
  • Webcast: Take the Safe Path to Creating ERP Value

    You know you cannot afford to handle the complexities of chargebacks, scalability, and compliance with solutions that don't add value to your bottom line. Considering moving forward with a new ERP solution? Watch this on demand webcast to learn how to avoid the pitfalls, and manage the risk, during all stages of your ERP project, so that you can enjoy the payoffs quickly and (relatively) painlessly.

    CDC Software
    01/11/2011
  • Webcast: Plant Scheduling Operations - Insights from Lonza to Improve Your Operations

    During this webinar Jeff O'Connor from Lonza will discuss a new approach to plant scheduling operations that enabled the company to reduce batch cycle time 25-30%, increase production throughput 20%, reduce manufacturing risk, improve production leveling and identify and alleviate process bottlenecks. Learn how companies like yours are utilizing this advanced solution to schedule real-world production processes, resulting in more agile and efficient manufacturing-and a healthier bottom line.

    01/11/2011
  • Market Intelligence Report: How Automated is Your Micro QC Lab?

    The pharmaceutical Quality Control lab is dramatically changing today, thanks in large part to technologies-such as rapid microbiological methods (RMMs)-which automate and accelerate traditional processes. We recently surveyed QC specialists in the industry about the extent to which they're automating their labs and implementing rapid methods. This PharmaManufacturing.com Market Intelligence Report draws a broad-brush picture of how the industry is progressing in this regard.

    11/30/2010
  • Unvarnished Truth: Solving the Case of the Migrating Molecule

    In the course of her work, Metrics Inc. scientist Deanna Williamson discovered that a component of label varnish had permeated an HDPE bottle and found its way into drug product. In this video from AAPS 2010, she shares her experience and lessons learned.

    11/24/2010
  • Webcast: Lean Pharma: Building a Sustainable Quality Culture During Times of Constant Change

    Although individual companies are achieving results by implementing Toyota Production System and other Lean methodologies, the pharmaceutical industry's Lean progress has been slow so far. In this program, McKinsey's Ulf Schrader, St. Gallen's Thomas Friedli, and NIPTE's Prabir Basu discuss what's holding pharma back from achieving true operational excellence, and what can be done to achieve lasting results and culture change, especially in an atmosphere dominated by mergers and acquisitions, downsizing, outsourcing and offshoring.

    11/05/2010
  • Webcast: Implementation of a Rapid Endotoxin Test System to Increase QC Lab Efficiency

    For those considering incorporating the PTS/MCS into their manufacturing and testing processes, this webcast will cover the details of implementation and its benefits. Attendees will also hear from a Charles River customer about their experiences switching to these rapid testing technologies, including how it impacted decision-making, validation and final outcome.

    10/20/2010
  • Market Intelligence Report: Tracking Your Workforce

    While many drug manufacturers are successfully tracking their workers in terms of attendance, skills, training, and habits, our recent survey shows there is much room for improvement. Most notably, there are still many manufacturers who are tracking workers on paper, or are not getting critical information that could be beneficial. This video, the first of a series of Market Intelligence Reports, provides an overview of our survey data and suggests how manufacturers can leverage workforce knowledge for operational improvement.

    10/18/2010
  • Webinar: Staying One Step Ahead of the FDA: Supplier Audits and Ensuring Raw Material Quality

    To avoid costly shutdowns, product seizures, and warning letters, drug firms need effective raw material controls and critical supplier auditing procedures. Imagine how effective your controls would be if you were using the same exact field sampling techniques and tools FDA investigators use. If you’d like to learn some of the lessons the FDA has adopted in the wake of the contaminated Heparin and Glycerin scandals, then attend this free webinar hosted by Thermo Fisher Scientific.

    08/31/2010
  • Focus on Pharma Episode 8: Pharmaceutical QbD: An Industry Progress Report Led By Ali Afnan

    Faster drug approvals, real-time release, regulatory relief. These, and many other benefits, are promised by adopting Pharmaceutical Quality by Design principles. So why aren't more people embracing the concept? Skeptics continue to see QbD efforts as too expensive, time consuming and impractical, while QbD and PAT projects are being launched separately, rather than together as intended. Exploring the reasons for this apparent disconnect, and potential solutions, are Ali Afnan, Pedro Hernandez-Abad, Sam Venugopal and Gawayne Mahboubian-Jones.

    08/26/2010
41-60 of 263 < first | | | last >